Effect of TXA Oral Sol 5% in Patients Treated With DOACs or VKA and Undergoing a Single or Multiple Tooth Extraction

NCT06143787 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

280

Enrollment

INDUSTRY

Sponsor class

Conditions

Bleeding From Teeth
Bleeding Prophylaxis

Interventions

DRUG: Tranexamic acid

Sponsor

Hyloris Developments